about
Sox11 is expressed in early progenitor human multipotent stromal cells and decreases with extensive expansion of the cellsMechanisms of mesenchymal stem/stromal cell functionPharmaceutical induction of ApoE secretion by multipotent mesenchymal stromal cells (MSCs).iPS-derived MSCs from an expandable bank to deliver a prodrug-converting enzyme that limits growth and metastases of human breast cancersCD133 identifies a human bone marrow stem/progenitor cell sub-population with a repertoire of secreted factors that protect against stroke.One strategy for cell and gene therapy: harnessing the power of adult stem cells to repair tissues.Bone regeneration with osteogenically enhanced mesenchymal stem cells and their extracellular matrix proteins.MSCs derived from iPSCs with a modified protocol are tumor-tropic but have much less potential to promote tumors than bone marrow MSCs.A simple critical-sized femoral defect model in mice.Pharmaceutical inhibition of glycogen synthetase kinase-3β reduces multiple myeloma-induced bone disease in a novel murine plasmacytoma xenograft modelScalable Production of a Multifunctional Protein (TSG-6) That Aggregates with Itself and the CHO Cells That Synthesize It.Adult bone marrow stem/progenitor cells (MSCs) are preconditioned by microenvironmental "niches" in culture: a two-stage hypothesis for regulation of MSC fate.Multipotent stromal cells are activated to reduce apoptosis in part by upregulation and secretion of stanniocalcin-1.A potential role for Dkk-1 in the pathogenesis of osteosarcoma predicts novel diagnostic and treatment strategiesThe promise of canonical Wnt signaling modulators in enhancing bone repair.An unexpected role for a Wnt-inhibitor: Dickkopf-1 triggers a novel cancer survival mechanism through modulation of aldehyde-dehydrogenase-1 activity.Repeated intra-articular injection of allogeneic mesenchymal stem cells causes an adverse response compared to autologous cells in the equine modelTheobromine Upregulates Osteogenesis by Human Mesenchymal Stem Cells In Vitro and Accelerates Bone Development in Rats.Comparison of the anti-inflammatory effects of induced pluripotent stem cell-derived and bone marrow-derived mesenchymal stromal cells in a murine model of corneal injury.A crosstalk between myeloma cells and marrow stromal cells stimulates production of DKK1 and interleukin-6: a potential role in the development of lytic bone disease and tumor progression in multiple myeloma.An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction.An allograft generated from adult stem cells and their secreted products efficiently fuses vertebrae in immunocompromised athymic rats and inhibits local immune responses.In-vitro characterization of canine multipotent stromal cells isolated from synovium, bone marrow, and adipose tissue: a donor-matched comparative study.Equal expression of typ X collagen mRNA fom mutant and wild type COL10A1 alleles in growth plate cartilage from a patient with metaphyseal chondrodysplasia type Schmid.Quantification of Escherichia coli genomic DNA contamination in recombinant protein preparations by polymerase chain reaction and affinity-based collection.Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy.Enhanced engraftment of mesenchymal stem cells in a cutaneous wound model by culture in allogenic species-specific serum and administration in fibrin constructs.More progress defining the crosstalk between multiple myeloma and mesenchymal stem cells of the bone marrow.Dkk-1-derived synthetic peptides and lithium chloride for the control and recovery of adult stem cells from bone marrow.Time-lapse microscopic observation of non-dividing cells in cultured human osteosarcoma MG-63 cell line.Metaphyseal chondrodysplasia type Schmid mutations are predicted to occur in two distinct three-dimensional clusters within type X collagen NC1 domains that retain the ability to trimerize.Human mesenchymal stem cell-derived matrices for enhanced osteoregeneration.Rapid Osteogenic Enhancement of Stem Cells in Human Bone Marrow Using a Glycogen-Synthease-Kinase-3-Beta Inhibitor Improves Osteogenic Efficacy In Vitro and In Vivo.The effects of the Er:YAG laser on trabecular bone micro-architecture: Comparison with conventional dental drilling by micro-computed tomographic and histological techniques.Assays of osteogenic differentiation by cultured human mesenchymal stem cells.Widespread changes in transcriptome profile of human mesenchymal stem cells induced by two-dimensional nanosilicates.In vitro MSC function is related to clinical reaction in vivoHow stem cell composition in bone marrow aspirate relates to clinical outcomes when used for cervical spine fusionThree-dimensional in vitro modeling of malignant bone disease recapitulates experimentally accessible mechanisms of osteoinhibitionMM-induced osteolysis: partners in crime
P50
Q24338730-A936829A-5A4D-4597-93DC-D6C5CDA326A4Q28079649-24FAAC99-FF63-4431-979A-1223886CCA64Q33372606-7FF89E47-362F-4452-8C79-367CD311DE19Q33458985-4799D782-870E-4659-903F-BA2B23C72097Q33713175-2175137E-03E2-47D0-A425-F9BBCB6F8B9AQ34582606-71FA73A0-0D81-44E7-9478-94A139FC4600Q34791252-78690C42-B8DB-49CC-849A-5E66F6749D09Q34985576-1EB8F6FE-8DC1-489D-8837-68451BD3AC66Q35459362-E4033DD6-0767-42DD-AB34-4B909B8888E8Q35868347-C1E6F19D-596E-4007-8F41-5A71F981043EQ35899925-0E4703CA-5E10-4CFB-A84A-F37E6B9E81B1Q36208443-75D7A31F-296D-4051-B427-B40305FC7F91Q36547021-5561B34F-BC4C-465F-80E1-CECC9B928F0FQ36610707-3B1AAA19-BC28-4C63-800C-9475E6DDD794Q36679276-E2C0ACB9-539E-4020-B507-25AAEEF6ACBAQ37620723-B2CE1D32-B7FB-433A-ABFA-E28FB84AB17BQ37671213-358FC908-4F51-4A03-AE64-710D8D0C40C0Q38376984-8711EF22-7823-4520-A94F-314F759116F1Q39191209-BF9F816A-C381-4EDB-A1F8-321A48CE31B1Q40350326-69C3B68A-9A82-4234-B03C-C60E6DF342E2Q40557435-27CAD0CB-681F-45B2-950E-C752C3CC0999Q42078228-F8B15E9A-A433-4DDB-969F-4C194D8EBD7AQ42281235-D91330FE-D4C1-40F8-A2A1-4F76DF19EB20Q43075812-DF3FE7CD-9F2C-4FFE-B51E-FAFDE86A0210Q43718004-5FC45903-BC0D-44AF-9A31-1E8B6BEC99F1Q44878272-110382D2-FABF-4519-901C-36593A17CA65Q45858942-E060037D-897B-4E0F-AA26-95EDA39476B5Q45871789-50FD3E44-1DA7-4108-BD47-983C1DB1C2D2Q45879029-2F0972B9-5A13-43AB-8FB8-6B92C3368B9AQ47423338-C5FF2C3E-E166-45E5-899D-BBB138FD2311Q47624116-CFC56FBE-CB36-420F-AC08-DADECB600858Q47816960-66459DD0-DE30-4FEA-AF56-AF1327462BFAQ48098707-BBDB74F1-02ED-4A23-8366-347AE2F4AC00Q49271367-A660822F-826C-47D6-ABC7-2C11B88188E8Q50541801-19B672C7-7259-4286-891C-3FD21F16A570Q52593321-46A15BB9-4646-49B5-978C-AF270AFCAAC3Q58590558-ABD64AA8-1617-4E0B-A7D5-6451AB7139FCQ58701468-B4FFB3E6-FBE8-4BAD-8A52-CCF2C03BF795Q59335355-DE61E6EB-E92F-403C-9F89-51D51EB45856Q81508444-DD1D8739-F823-46E3-940B-8F32F2DC11A7
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Carl A Gregory
@ast
Carl A Gregory
@en
Carl A Gregory
@es
Carl A Gregory
@sl
type
label
Carl A Gregory
@ast
Carl A Gregory
@en
Carl A Gregory
@es
Carl A Gregory
@sl
altLabel
Carl Gregory
@en
prefLabel
Carl A Gregory
@ast
Carl A Gregory
@en
Carl A Gregory
@es
Carl A Gregory
@sl
P106
P21
P31
P496
0000-0001-6444-5541